Aikeno Bio

爱科诺生物

Aikeno Bio

Biotech/Healthcare

Aikenuo Bio develops innovative small-molecule drugs. The company studies the cell death-inflammation circuit, a shared mechanism underlying multiple major diseases, and independently develops potential first-in-class small molecules for inflammatory, fibrotic, autoimmune, and oncological diseases…

Latest round: Series C (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-05-01